Sirid-Aimée Kellermann

Title: Sirid-Aimée Kellermann: Innovator in Human Antibodies

Introduction

Sirid-Aimée Kellermann is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of 6 patents to his name, Kellermann's work has advanced the understanding and treatment of various medical conditions.

Latest Patents

Kellermann's latest patents focus on human antibodies that bind to human MAdCAM. The first patent describes antibodies and antigen-binding portions that specifically target MAdCAM, inhibiting its function. These antibodies are derived from a hybridoma cell line and include specific amino acid sequences. The invention also encompasses nucleic acid molecules encoding these antibodies, methods of making and using them, and compositions that include these antibodies. Another patent elaborates on human anti-MAdCAM antibodies, detailing their chimeric, bispecific, and derivatized forms. This patent also discusses gene therapy methods utilizing nucleic acid molecules that encode the immunoglobulin molecules, as well as the creation of transgenic animals or plants containing these nucleic acids.

Career Highlights

Throughout his career, Kellermann has worked with prominent companies such as Amgen Fremont Inc. and Warner-Lambert Company. His experience in these organizations has contributed to his expertise in the field of antibody research and development.

Collaborations

Kellermann has collaborated with notable colleagues, including Mary Haak-Frendscho and Vahe Bedian. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Sirid-Aimée Kellermann's contributions to the field of human antibodies have paved the way for advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through biotechnology.